Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1042 of 1,261

  1. US 7485709

    Identification of a novel BHD gene

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  2. US 7485627

    Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation

    The Regents of the University of California · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  3. US 7485651

    Compounds with activity on muscarinic receptors

    ACADIA Pharmaceuticals Inc. · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  4. US 7485451

    Storage stable compositions of biological materials

    The Regents of the University of California · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  5. US 7485440

    Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  6. US 7485457

    Isolated/cloned human NT2 cell lines expressing serotonin and GABA

    The United States of America—Department of Veterans Affairs · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  7. US 7485724

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  8. US 7485317

    Thermo-reversible polymer for intralumenal implant

    The Regents of the University of California · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  9. US 7485307

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  10. US 7485311

    Methods and compositions for preventing and treating male erectile dysfunction

    The Regents of the University of California · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  11. US 7482470

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  12. US 7482489

    Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  13. US 7482319

    Vault and vault-like carrier molecules

    The Regents of the University of California · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  14. US 7482002

    Method of administering and using VEGF inhibitors for the treatment of prostate cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  15. US 7482351

    4-pyrimidineamine compounds and their uses as anti-proliferative agents

    Rigel Pharmaceuticals, Inc. · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  16. US 7481995

    Aerosol composition

    University College Cardiff Consultants Limited · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  17. US 7482331

    Diagnosis and treatment of myocardial failure

    The Regents of the University of Colorado · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  18. US 7482024

    Compositions comprising an active agent

    Nektar Therapeutics · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  19. US 7481212

    Increased dosage metered dose inhaler

    Nektar Therapeutics · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  20. US 7482150

    Virulent systemic feline calicivirus

    The Regents of the University of California · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  21. US 7479562

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  22. US 7479579

    Triple transgenic mouse model of Alzheimer's disease

    The Regents of the University of California · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  23. US 7479550

    Amyloid β gene vaccines

    The Board of Regents of the University of Texas System · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  24. US 7479551

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.